SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 485 filers reported holding SEAGEN INC in Q1 2021. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $833,751 | +31.4% | 3,780 | +14.6% | 0.01% | -33.3% |
| Q2 2023 | $634,734 | -12.8% | 3,298 | -8.3% | 0.01% | -25.0% |
| Q1 2023 | $728,285 | -37.8% | 3,597 | -54.4% | 0.01% | +20.0% |
| Q4 2022 | $1,169,991 | +5.6% | 7,892 | +1.2% | 0.01% | 0.0% |
| Q3 2022 | $1,108,290 | +58.5% | 7,799 | +97.3% | 0.01% | -33.3% |
| Q2 2022 | $699,268 | +76.1% | 3,952 | +51.5% | 0.02% | +66.7% |
| Q1 2022 | $397,000 | +21.0% | 2,608 | +22.8% | 0.01% | +12.5% |
| Q4 2021 | $328,000 | +2.2% | 2,124 | +12.4% | 0.01% | -11.1% |
| Q3 2021 | $321,000 | +28.9% | 1,889 | +19.9% | 0.01% | +28.6% |
| Q2 2021 | $249,000 | +20.3% | 1,576 | +5.9% | 0.01% | 0.0% |
| Q1 2021 | $207,000 | +567.7% | 1,488 | +745.5% | 0.01% | +600.0% |
| Q4 2020 | $31,000 | – | 176 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $6,419,005,000 | 42.04% |
| Ally Bridge Group (NY) LLC | 92,506 | $12,658,000 | 8.36% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 166,200 | $22,739,000 | 7.29% |
| Eagle Health Investments LP | 174,902 | $23,932,000 | 5.49% |
| Avoro Capital Advisors LLC | 1,865,000 | $255,188,000 | 4.71% |
| Lagoda Investment Management, L.P. | 47,955 | $6,562,000 | 4.67% |
| Nan Fung Group Holdings Ltd | 47,096 | $6,444,000 | 4.11% |
| Ikarian Capital, LLC | 150,000 | $20,525,000 | 4.09% |
| Antara Capital LP | 946,100 | $129,455,000 | 3.42% |
| SECTOR GAMMA AS | 84,730 | $11,594,000 | 2.99% |